Expert Interview
A Fourth Take: Discussing the potential of VUITY in treating presbyopia
Ticker(s): ABBVInstitution: Kaiser Permanente
-
Patients with presbyopia are probably 80% of who I see each day. I wouldn’t be able to estimate a total number….massive. I work in a very big and busy medical center.
-
I’m familiar with Vuity but have not prescribed it to date.
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
